東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Investigations into RNA-Based Therap...

Maes, Nyree Evonne.

FindBook

Google Book

Amazon

博客來

Investigations into RNA-Based Therapeutics for Flavivirus Infections.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Investigations into RNA-Based Therapeutics for Flavivirus Infections./
作者:	Maes, Nyree Evonne.
面頁冊數:	160 p.
附註:	Source: Dissertation Abstracts International, Volume: 75-09(E), Section: B.
Contained By:	Dissertation Abstracts International75-09B(E).
標題:	Microbiology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3580761
ISBN:	9781321054026

Investigations into RNA-Based Therapeutics for Flavivirus Infections.
Maes, Nyree Evonne.

Investigations into RNA-Based Therapeutics for Flavivirus Infections. - 160 p.

Source: Dissertation Abstracts International, Volume: 75-09(E), Section: B.

Thesis (Ph.D.)--Yale University, 2014.

This item must not be sold to any third party vendors.

Medically important flaviviruses, such as dengue (DENV) and West Nile (WNV) viruses, have displayed a tremendous ability to rapidly invade and coexist with other flaviviruses in new geographical areas. Vaccines and treatments for most of these viruses are lacking, warranting an urgent need for the development of inhibitors. Throughout this dissertation, I will describe our investigations into RNA-based therapeutics that were conducted with the goal of developing treatments for flavivirus infections. The work includes using intranasal administration as a portal of delivery for a small interfering RNA (siRNA) targeting the WNV envelope gene sequence as treatment for encephalitis caused by WNV. The data show that intranasal (i.n.) siRNA treatment can rescue mice from lethal WNV infection as late as 2-3 days prior to death. Importantly, i.n.-treated mice that survived primary WNV challenge were immune to a secondary WNV infection, indicating the potential of this approach in inducing protective immunity. Further, this work encompasses the design and characterization of a mismatched siRNA targeting the conserved 3' cyclization sequence (3'CS) that maps to the highly structured 3' untranslated region (3'UTR) of mosquito-borne flaviviruses, which is considered poorly accessible for binding by antisense molecules. The mismatched siRNA, msi3CS, demonstrates its potential for cross-inhibiting multiple flaviviruses including DENV-2, DENV-4 and WNV in cultured cells. Treatment of mice with msi3CS enabled protection against WNV encephalitis but was dependent on time of administration and host immune competence. Lastly, this work investigates the potential therapeutic use of an anti-apoptotic peptide during WNV infection for reducing neuropathology. These investigations reveal that the anti-apoptotic peptide surprisingly aids WNV-induced mortality indicating that reducing neuropathology alone may not be sufficient to improve prognosis.

ISBN: 9781321054026Subjects--Topical Terms:

536250
Microbiology.

Investigations into RNA-Based Therapeutics for Flavivirus Infections.
LDR:02959nmm a2200301 4500 001 2058338
005 20150714101033.5
008 170521s2014 ||||||||||||||||| ||eng d
020 $a 9781321054026
035 $a (MiAaPQ)AAI3580761
035 $a AAI3580761
040 $a MiAaPQ $c MiAaPQ
100 1 $a Maes, Nyree Evonne. $3 3172282
245 1 0 $a Investigations into RNA-Based Therapeutics for Flavivirus Infections.
300 $a 160 p.
500 $a Source: Dissertation Abstracts International, Volume: 75-09(E), Section: B.
500 $a Adviser: Priti Kumar.
502 $a Thesis (Ph.D.)--Yale University, 2014.
506 $a This item must not be sold to any third party vendors.
506 $a This item must not be added to any third party search indexes.
520 $a Medically important flaviviruses, such as dengue (DENV) and West Nile (WNV) viruses, have displayed a tremendous ability to rapidly invade and coexist with other flaviviruses in new geographical areas. Vaccines and treatments for most of these viruses are lacking, warranting an urgent need for the development of inhibitors. Throughout this dissertation, I will describe our investigations into RNA-based therapeutics that were conducted with the goal of developing treatments for flavivirus infections. The work includes using intranasal administration as a portal of delivery for a small interfering RNA (siRNA) targeting the WNV envelope gene sequence as treatment for encephalitis caused by WNV. The data show that intranasal (i.n.) siRNA treatment can rescue mice from lethal WNV infection as late as 2-3 days prior to death. Importantly, i.n.-treated mice that survived primary WNV challenge were immune to a secondary WNV infection, indicating the potential of this approach in inducing protective immunity. Further, this work encompasses the design and characterization of a mismatched siRNA targeting the conserved 3' cyclization sequence (3'CS) that maps to the highly structured 3' untranslated region (3'UTR) of mosquito-borne flaviviruses, which is considered poorly accessible for binding by antisense molecules. The mismatched siRNA, msi3CS, demonstrates its potential for cross-inhibiting multiple flaviviruses including DENV-2, DENV-4 and WNV in cultured cells. Treatment of mice with msi3CS enabled protection against WNV encephalitis but was dependent on time of administration and host immune competence. Lastly, this work investigates the potential therapeutic use of an anti-apoptotic peptide during WNV infection for reducing neuropathology. These investigations reveal that the anti-apoptotic peptide surprisingly aids WNV-induced mortality indicating that reducing neuropathology alone may not be sufficient to improve prognosis.
590 $a School code: 0265.
650 4 $a Microbiology. $3 536250
650 4 $a Virology. $3 642304
690 $a 0410
690 $a 0720
710 2 $a Yale University. $3 515640
773 0 $t Dissertation Abstracts International $g 75-09B(E).
790 $a 0265
791 $a Ph.D.
792 $a 2014
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3580761